HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sublingual versus vaginal misoprostol for the management of missed abortion.

AbstractAIM:
To evaluate the efficacy of two routes of misoprostol administration (sublingual and vaginal) for the treatment of missed abortion.
METHODS:
Two hundred and twenty women with confirmed missed abortion who received 400 microg/6 h misoprostol either sublingually or vaginally, were included in this randomized control trial. All women were admitted to hospital for follow-up care for 2 days. If the pregnancy was not completely evacuated during this time, the patient underwent immediate surgical completion. Efficacy was defined as the percentage of women discharged from the study without the need for surgical intervention.
RESULTS:
The effectiveness was high in the sublingual group and statistically different (sublingual 84.5%, vaginal 46.4% P = 0.000 RR = 0.54 95%CI = 0.442-0.681). The groups differed in terms of complications like bleeding (88.2% vs 65.5%), pain (85.5% vs 56.4%), diarrhea (69.1% vs 36.4%) and fever (23.6% vs 13.3%) in the sublingual group versus the vaginal group, but the mean time to expulsion was shorter (9.68 h SD = 5.51 95%CI = 8.61-10.57) in the sublingual group than the vaginal group (16.64 h SD = 14.01 95%CI = 13.8-19.48), P = 0.000. Women in the sublingual group were highly satisfied with the method.
CONCLUSION:
Sublingual misoprostol for the medical management of missed abortion is more effective and more acceptable than the vaginal route. However, it showed more adverse effects.
AuthorsFateme Davari Tanha, Mohadeseh Feizi, Mamak Shariat
JournalThe journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 36 Issue 3 Pg. 525-32 (Jun 2010) ISSN: 1447-0756 [Electronic] Australia
PMID20598032 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
Topics
  • Abortifacient Agents, Nonsteroidal (administration & dosage, therapeutic use)
  • Abortion, Induced (methods)
  • Abortion, Missed (drug therapy)
  • Administration, Intravaginal
  • Administration, Sublingual
  • Female
  • Humans
  • Misoprostol (administration & dosage, therapeutic use)
  • Patient Satisfaction
  • Pregnancy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: